[EN] PESTICIDALLY ACTIVE PYRROLE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRROLE ACTIFS SUR LE PLAN PESTICIDE
申请人:SYNGENTA PARTICIPATIONS AG
公开号:WO2019068819A1
公开(公告)日:2019-04-11
Compounds of formula (I) as defined herein, to processes for preparing them, to pesticidal, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.
[EN] PROCESS FOR THE PREPARATION OF 5-FLUORO-1H-PYRAZOLES STARTING FROM HEXAFLUOROPROPENE<br/>[FR] PROCÉDÉ DE PRÉPARATION DE 5-FLUORO-1H-PYRAZOLES À PARTIR D'HEXAFLUOROPROPÈNE
申请人:BAYER CROPSCIENCE AG
公开号:WO2015181139A1
公开(公告)日:2015-12-03
A new process for the preparation of 5-fluoro-1H-pyrazoles of the general formula (I)as described herein and further reactions with this compound.
这里描述了一种制备通式(I)中5-氟-1H-吡唑的新工艺,以及与该化合物的进一步反应。
[EN] BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR<br/>[FR] INHIBITEURS BENZAMIDIQUES DU RECEPTEUR P2X7
申请人:PFIZER PROD INC
公开号:WO2004099146A1
公开(公告)日:2004-11-18
The present invention provides benzamide inhibitors of the P2X7 receptor of the formula (I), wherein R1 -R3 are as defined herein. The compounds of the invention are useful in the treatment of IL-1 mediated disorders, including, without limitation, inflammatory diseases such as osteoarthritis and rheumatoid arthritis; allergies, asthma, COPD, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
[EN] PROCESS FOR THE PREPARATION OF 5-FLUORO-1H-PYRAZOLES<br/>[FR] PROCÉDÉ POUR LA PRÉPARATION DE 5-FLUORO-1H-PYRAZOLES
申请人:BAYER CROPSCIENCE AG
公开号:WO2015078846A1
公开(公告)日:2015-06-04
A new process for the preparation of 5-fluoro-1H-pyrazoles of the general formula (I) as described herein, resulting from the reaction of an olefin with hydrazine in the presence of water and a base.
[EN] PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS<br/>[FR] DÉRIVÉS DE PHTALAZINONE EN TANT QU'INHIBITEURS DE MPGES-1
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2013072825A1
公开(公告)日:2013-05-23
The present patent application is directed to bicyclic compounds of formula (I) or pharmaceutically acceptable salt thereof as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (m PGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.